| Literature DB >> 27084396 |
Fredrik Ahlin1, John Arfvidsson1, Kris G Vargas2, Stefan Stojkovic3, Kurt Huber4, Johann Wojta5.
Abstract
Coronary artery disease (CAD) and its complications remain the most common cause of death worldwide. Cardiac troponins (cTn) are standard biomarkers used today for diagnosis and risk stratification of myocardial infarction (MI). Increasing efforts are made to develop additional, new biomarkers for more effective and safe rule-in and rule-out of MI patients at the emergency department. During the past decade, microRNAs (miRNAs) have emerged as new, potential diagnostic biomarkers in several diseases, including MI. In this review, we aimed to summarize some of the prominent studies in the field, and discuss the potential value of miRNAs in the diagnosis of MI.Entities:
Keywords: Acute coronary syndrome; Biomarker; MicroRNA; Troponin
Mesh：
Substances：
Year: 2016 PMID： 27084396 DOI： 10.1016/j.vph.2016.04.001
Source DB: PubMed Journal: Vascul Pharmacol ISSN： 1537-1891 Impact factor: 5.773